SCHEMBL17845561

SCHEMBL17845561

Cc1nnc(N2CN(C)c3c(F)cc(S(=O)(=O)Cl)cc32)s1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 7/20 0.37
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17845401 0.78 PARG (0.38) PARGPOLB
SCHEMBL17845404 0.68 PARG (0.68) PARG
SCHEMBL31122052 0.60 PARG (0.68) PARG
SCHEMBL17845484 0.59 PARG (0.70) PARG
SCHEMBL17845403 0.56 PARG (0.67) PARG
SCHEMBL31122072 0.56 PARG (0.67) PARG
SCHEMBL282282 0.55 CA1 (0.41)
SCHEMBL16908459 0.53 CA1 (0.35)
SCHEMBL19748545 0.53 CA1 (0.43)
SCHEMBL6180421 0.53 SOS1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233845-A1 PARG INHIBITORY COMPOUNDS Cancer Research Technology Limited (GB) 2017-10-25 EP disclosed
WO-2016097749-A1 PARG INHIBITORY COMPOUNDS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-06-23 WO disclosed